In Norway, no difference in survival has been found between squamous epithelial cancer and adenocarcinoma (8
There is not a great difference in survival among the different types of adenocarcinomas (14). Small cell cancer with neuroendocrine differentiation is associated with poor prognosis.
Younger women have longer survival mainly due to early stage diagnosis. In stage I, the size of the tumor, depth of invasion, invasion of lymph vessels, and nodal metastasis are significant for survival. (9–10,12). Uterine invasion aggravate the prognosis (14), as does extensive lymph node metastasis including paraaortal lymph nodes (12).
Five-year relative survival for patients with cervical cancer, in percent, according to stage and diagnosis period 1974–2013.
Source: Cancer Registry of Norway
All stages combined, survival in Norway is 78%.